Artiva Biotherapeutics, Inc.
(ARTV - NASDAQ)
10,22 USD
📋 Profilo Aziendale

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer.

|